Multiple Myeloma and EasyM Resource Centre.
Featured
Comparison of EasyM Clonotypic Mass Spectrometry and EuroFlow MRD in Multiple Myeloma
Iain Rogers2025-03-04T10:05:19-05:00March 3rd, 2025|Publication|
Mass Spectrometry Testing in Multiple Myeloma
Iain Rogers2025-02-24T16:20:23-05:00February 11th, 2025|Articles|
M-spike and Multiple Myeloma
Iain Rogers2025-02-24T16:20:40-05:00February 5th, 2025|Articles|
Publications, Posters & Case Studies
Jenna Kerry2025-05-12T11:32:03-04:00
Opportunities and Challenges for MRD Assessment in the Clinical Management of Multiple Myeloma
Jenna Kerry2025-05-12T11:32:03-04:00May 12th, 2025|Publication|
Iain Rogers2025-03-04T10:05:19-05:00
Comparison of EasyM Clonotypic Mass Spectrometry and EuroFlow MRD in Multiple Myeloma
Iain Rogers2025-03-04T10:05:19-05:00March 3rd, 2025|Publication|
Iain Rogers2025-02-28T09:22:26-05:00
Measurable Residual Disease and Decision-Making in Multiple Myeloma
Iain Rogers2025-02-28T09:22:26-05:00August 3rd, 2024|Case Studies|